Integration & scale
Heterogeneous devices, legacy software and data systems must act like modules rather than one-off engineering projects.
On 23 September 2026, the Bits in Bio Journal Club put two papers on self-driving laboratories beside the daily reality of samples, instruments, failure recovery and the people who keep a lab running. This field guide accompanies that discussion.
Automation performs a procedure. Autonomy uses evidence to decide what happens next. A self-driving laboratory needs both, with boundaries that scientists can see and change.
The steps are defined in advance. The machine may be very capable without choosing the next experiment.
The system senses state, evaluates evidence and selects or adapts an action inside a defined authority boundary.
This ICRA workshop paper gives the discussion a map of the whole system. It draws attention to dependencies that a single-device demonstration can hide.
Heterogeneous devices, legacy software and data systems must act like modules rather than one-off engineering projects.
Models of devices and workflows can support simulation, commissioning, diagnosis and explanation. Their fidelity has to be tested against the lab.
Ask what decisions the system owns, under which conditions, and what role people retain. “Human in the loop” is a deliberate design choice.
Language and multimodal models can read, translate and interpret. Classical ML, optimization and control remain essential.
Shared interfaces, data structures and laboratory objects reduce integration cost. They work only when vendors and institutions adopt them.
Reproducibility, safety, sustainability, dual use and workforce skills belong inside the architecture.
The scientific opportunity is a better division of work, with human judgement used where it earns its keep.
A-Lab linked computed targets, literature-derived recipes, robotic solid handling, furnaces, X-ray diffraction, machine interpretation and active learning for a 17-day autonomous campaign.
A-Lab integrated the full evidence loop instead of automating one task. It also turned failures into scientific evidence: slow kinetics, model error, volatility, amorphous products and metastability became diagnoses rather than invisible waste.
There was no matched human or random-search baseline. Majority target phase is not necessarily a pure, useful material. Seventeen days is not long-term operations, and one inorganic platform is not a template for every wet lab.
These are anonymized, paraphrased themes from the 23 September 2026 discussion. They record what this group saw; they are not a representative survey.
| Layer | What the papers anticipate | What practitioners encounter | Useful response |
|---|---|---|---|
| Planning | AI proposes experiments and mines literature. | A plan fails if it does not know local inventory, SOPs, device limits or authorization. | Ground models in machine-readable capabilities and explicit uncertainty. |
| Execution | Flexible robots run complex protocols. | Samples arrive in odd containers; consumables vary; devices jam; assays change. | Normalize inputs, expose device state, design retries and exception queues. |
| Measurement | Automated analytics generate reproducible evidence. | Queues, calibration drift, ambiguous signals and hand-offs still dominate. | Inline QC, orthogonal evidence, calibration checks and provenance. |
| Learning | Active learning chooses informative next experiments. | Objectives are unstable, multi-objective or tacit; data are sparse and biased. | Bound the search and preserve scientist-defined stop rules. |
| Digital twins | Simulation helps plan and explain the lab. | A twin of discovery biology can be confidently wrong. | Start with scheduling, device state, error injection and process scale-up. |
| Standards | Common interfaces enable modularity. | Legacy devices, partial implementations and vendor lock-in persist. | Standardize capability and data layers; maintain tested adapters. |
| People | Humans retain creativity and oversight. | Trust turns on agency, space, roles, maintenance and mid-run intervention. | Co-design authority, escalation and evidence review. |
| Safety | Automation removes people from hazards. | AI intent, translation and biased learning create additional failure modes. | Use interlocks, authorization, monitoring, safe states and auditable evidence. |
These blocks collect recurring ideas from the discussion. They are anonymised and paraphrased, with no claim that every participant held the same view.
Several participants described assays that become automated only after someone receives the sample, fixes its metadata, adjusts the concentration and moves it into a standard plate. Map from the first uncontrolled input, or the labour simply moves upstream.
A production line expects stable inputs. Assay development changes the method because the lab is still learning. That makes recovery, editable protocols and clear run state more useful than a perfect run under one fixed condition.
The room trusted twins for scheduling, collision checks, liquid-handler simulation and commissioning. Confidence fell when a model claimed to stand in for novel chemistry or human biology. Fidelity has to be shown for the exact decision at hand.
Some services described as autonomous still need a software engineer to watch them and clear faults. Participants wanted remote monitoring, permissioned mid-run changes and a record that survives a restart.
Automation can reduce injury and free scientists from repetitive work. It may also remove the bench repetition through which junior staff learn to spot trouble. Training now needs deviation diagnosis, trace review and method validation.
Participants contrasted self-driving-lab ambition with laboratories that still redraw plots by hand or compare documents manually. Sample identity, metadata and routine data movement are the first layer of autonomy.
Twenty sequential steps, each 99% reliable, produce only 0.9920 = 81.8% whole-run success. Roughly one run in five fails somewhere.
CELISCA is the Center for Life Science Automation at the University of Rostock. Rostock is a city in northeastern Germany on the Baltic coast.
MOLAR vehicles move trays and labware between distributed stations, including across two floors via automatic doors and elevators, under supervisory control.
Mobile logistics can connect valuable islands of automation without forcing every instrument into a single monolithic cell. The 2025 paper reported six integrated workstations and six months of operation.
CELISCA’s 2026 work coordinates a liquid handler, collaborative interface robot and mobile robot for enzymatic assays. The focus has moved from transport alone to multi-robot coordination.
Sources: Huang et al., SLAS Technology (2025), DOI 10.1016/j.slast.2024.100240; CELISCA 2026 research updates. System-specific results should not be generalized without cross-site validation.
Recent work asks how to assess, observe, transfer and govern autonomous laboratories after the first system has been built.
Plate-based liquid handling
Scheduled analytics
High-throughput screening
Standard sample formats
Orchestration layers
Multimodal anomaly detection
Bounded agents
Mobile logistics
Digital commissioning
Unstructured sample intake
Assay variability
General exception recovery
Cross-vendor portability
Proof of better science
A 2026 assessment method evaluates autonomous lab robotics across adaptability and learning, dexterity, perception and task complexity.
Digital-twin work expands simulation across robots, devices, fluids, powders, heat and reaction behavior.
A web interface reduces the coding barrier for cross-platform workflow design and autonomous runs.
Multimodal sensing and vision-language diagnosis help a robotic electrocatalyst platform recognize anomalies.
A proposed architecture separates AI-generated intent from authorized execution, monitoring and trustworthy evidence.
Laboratory search is linked to representative devices and industrial constraints, rather than optimised in isolation.
Confidence is highest where standards and deployed systems already point in the same direction.
More labs map device capabilities, states, data pathways and failure modes. Observability improves before deep autonomy.
Agents retrieve SOPs, translate intent, monitor runs and prepare evidence packages; humans approve consequential actions.
Vision and multimodal sensing move into labware verification, fault detection and recovery.
Workcell, scheduling and process twins support commissioning, error injection and scale translation. Broad biological twins remain limited.
Large facilities connect specialized stations with mobile logistics. Smaller labs favor modular cells and service models.
Capital-rich and high-throughput organisations run with more autonomy; many research labs use partial automation and shared facilities.
Modular acceleration. Labs add autonomy workflow by workflow, with strong human supervision and better evidence capture.
Platform concentration. Integration cost centralizes capability in large organizations and specialized service providers.
Trust shock. A safety or provenance failure slows deployment and produces stricter authorization and liability rules.
A staged route from a visible workflow to a bounded, evidence-producing loop.
Define the scientific, quality, safety or capacity problem and measure the baseline.
Start at the first uncontrolled input and end at the first decision-ready output.
Normalize identifiers, containers, metadata, SOP versions and acceptance criteria.
Capture device state, calibration, timestamps, errors and maintenance context.
Choose repetitive, valuable and observable work with a manual recovery path.
Let measurement select the next action inside a constrained, approved search space.
Inject missing samples, bad labels, device faults, drift and network loss.
Add devices and agents through reusable capabilities, data contracts and continuous governance.
An experimental system linking planning, automated execution, measurement and iterative decision-making.
A method that chooses the next experiment to improve a model or objective efficiently.
Coordination of instruments, software, data, schedules and dependencies across a workflow.
A computational representation of a physical asset or process, synchronized and validated for a defined use.
The ability to infer system state from logs, events, sensors and evidence.
Autonomous decisions restricted to a validated domain, hazard envelope and capability set.
The trace of materials, methods, versions, actions and transformations that produced a result.
Detecting a deviation, reaching a safe state and resuming or terminating without corrupting the evidence.
Meeting source: Bits in Bio Journal Club, “Self-Driving Labs,” 23 September 2026. Operational comments in this guide are anonymized and paraphrased. Forecasts are explicitly marked as outlook, not fact.